Case Report | DOI: https://doi.org/10.31579/2692-9759/171
University Of Medicine and Pharmacy Cardiology Department, Avicenne Military Hospital, Marrakech, Morocco.
*Corresponding Author: Yassine Alfatihi, University of Medicine and Pharmacy Cardiology Department, Avicenne Military Hospital, Marrakech, Morocco.
Citation: Yassine Alfatihi, Yassine Zerhari, Anas Zbitou, Hamid Jallal, Abdelmajid Bouzerda, (2025), Cardiac Metastasis of Pulmonary Adenocarcinoma: Case Report, Cardiology Research and Reports, 7(5); DOI:10.31579/2692-9759/171
Copyright: © 2025, Yassine Alfatihi. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Received: 25 August 2025 | Accepted: 02 September 2025 | Published: 15 September 2025
Keywords: secondary cardiac tumors; poor prognosis; advanced primary tumor; pulmonary adenocarcinoma; chest-abdomen-pelvis (cap) ct scan
Secondary cardiac tumors are a serious and relatively rare pathology, typically associated with an advanced stage of the primary tumor and consequently with a poor prognosis. We report the case of a 72-year-old patient followed for pulmonary adenocarcinoma who underwent a chest-abdomen-pelvis (CAP) CT scan as part of a staging workup.
Lung cancer is the leading cause of cancer-related death in both men and women worldwide. Primary pulmonary carcinoma spreading to pulmonary vessels is relatively rare, and only a few individual cases have been reported in the medical literature [1].
A previously healthy 72-year-old patient consulted his general practitioner due to general health deterioration and a weight loss of 10 kg over 2 months. He did not report any specific symptoms except for anorexia, exertional dyspnea, and a chronic cough.
His medical history revealed that he had been smoking two packs of cigarettes per day since the age of 30. On physical examination, the patient showed signs of general decline but no dyspnea at rest. Cardiac auscultation was normal. Pulmonary auscultation revealed the absence of breath sounds in the left lung field.
A chest CT scan revealed a left pulmonary mass, and the histopathological examination confirmed a pulmonary adenocarcinoma. He was referred to us for a CAP CT scan as part of the staging evaluation.
The CT scan showed a left hilar mass syndrome extending 10 cm anteroposteriorly, (Figure A) crossing the midline with multiple lymphadenopathies near the pulmonary artery trunk, as well as a well-defined, oval mass in the left atrium with the same density as the pulmonary mass, in addition to adrenal and brain involvement.

Figure A: CT scan showed a left hilar mass syndrome extending 10 cm anteroposteriorly
Secondary cardiac tumors are rare but serious clinical entities. Malignant tumors can spread to the heart via direct infiltration (figure B), hematogenous metastases, lymphatic metastases, or transvenous extension. For example, renal cell, testicular, and hepatocellular carcinomas can sometimes extend into the inferior vena cava and gradually reach the right atrium. Pulmonary tumors can directly invade the heart through the pulmonary veins. This is a rare occurrence, especially when the lung tumor is small and located far from the heart [3]. Cardiac invasion is generally associated with poor prognosis.
Clinically, left heart invasion can be life-threatening, leading to complications such as pulmonary venous obstruction [4], cardiac tamponade [5], ventricular arrhythmias [6], complete atrioventricular block [7], left ventricular outflow obstruction [8], and myocardial infarction [9].

Figure B: Echocardiography showing a mass in the left atrium
Thrombus formation in the pulmonary artery due to direct tumor invasion has also been reported [10]. Anticoagulant therapy is generally the treatment of choice in cases of intracardiac thrombus. Moreover, malignant thrombus in the left superior pulmonary vein with intracardiac extension appears to result from direct intravascular spread of the disease. These patients are at high risk of sudden cardiac arrest due to pulmonary artery obstruction, mitral valve inflow blockage, or massive tumor emboli affecting major organs [11].
In a previous review of 215 lung cancer patients studied with gadolinium-enhanced 3D MR angiography, involvement of the proximal pulmonary veins and left atrial extension was found in 9 (4.2%) and 2 (0.9%) patients, respectively [12]. Similarly, a more recent retrospective analysis of 4668 patients who underwent surgery for lung cancer found pathological signs of pulmonary vein and left atrial involvement in 34 (0.7%) and 25 (0.5%) cases, respectively [13].
Bronchogenic carcinoma develops around the bronchus and may encase pulmonary vessels. As these are low-pressure vascular structures, extrinsic compression and occlusion can occur. This should not be misinterpreted as a vascular "cut-off" due to embolism. The key is a tapered narrowing caused by extrinsic compression, as opposed to a sharp transition typical of embolism.
Tumors can also invade the pulmonary artery. Tumors arising in the pulmonary arteries include angiosarcoma and tumor emboli from other organs. They are a rare but important differential diagnosis of pulmonary embolism [14].
Patients most often present with symptoms related to lung cancer (e.g., cough, hemoptysis, weight loss) or sometimes with cardiac complications at the time of first clinical presentation.
Although patients with cardiac metastases generally have poor clinical outcomes, their management should include a careful evaluation of surgical options. If possible, the treatment of choice is complete surgical resection combined with chemotherapy or radiotherapy.
Unfortunately, this was not the case for our patient, who had multiple metastases and thus advanced-stage disease.
After thorough clinical evaluation, the patient was deemed to be at too high risk for thoracic or brain surgery. Moreover, complete tumor resection is not always feasible, and postoperative mortality is relatively high.
In such cases, cardiac treatment is generally limited to palliative interventions aimed at relieving cardiac compression or hemodynamic obstruction if indicated, along with careful anticoagulant therapy.
Cardiac metastases from pulmonary adenocarcinoma are rare and indicate advanced disease, where the prognosis is poor and treatment is often symptomatic and palliative.
Dear Editorial Team, Clinical Medical Reviews and Reports. My experience with the journal was highly positive. The peer-review process was rigorous, constructive, and completed in a timely manner. The reviewers provided valuable comments that helped improve the quality and clarity of our manuscript. The editorial office was professional, responsive, and supportive throughout all stages of the publication process. Communication was clear and efficient, and any questions were addressed promptly. Overall, I found the journal to maintain high scientific standards and an excellent publication workflow. I would be pleased to consider submitting future work to this journal. Best wishes from, Elena Popa.
It was my pleasure to submit my testimonial concerning the Reviewer Board of our Scientific Journal “Brain and Neurological Disorders”. The Reviewers focused on some modifications and their contribution was helpful. The ladies of our Editorial Office were also supported my efforts. It was my honor to have such a co-operation and I am looking forward for more collaboration.
Dear Grace Pierce, Editorial Coordinator of Journal of Clinical Research and Reports, Thank you for the speedy and efficient peer review process. I appreciate the fact that your peer reviewers do not take months to respond like with some other journals. I would also like to thank the editorial office for responding quickly to my questions. It is an excellent journal. I plan to submit more manuscripts in the future. Best wishes from, Robert W. McGee
Dear Grace Pierce, Editorial Coordinator of Journal of Clinical Research and Reports, Working with you and your team on our recent publication in JCRR has been a truly wonderful and enjoyable experience. The responses were prompt, and the reviewers were patient, constructive, and highly professional. One reviewer in particular gave me the feeling that a professor was carefully reading and commenting on my coursework, which was deeply touching. The entire process was straightforward and hassle‑free, with no tedious online forms to complete. I highly recommend this journal. Best wishes from, DR Aibing Rao, Head of R&D
I Appreciate the Opportunity to Share my Experience with the Journal of Clinical Research and Reports. The peer review process was timely and constructive, and the feedback provided helped improve the quality of our manuscript. The editorial office was professional, responsive, and supportive throughout the process, ensuring smooth communication and efficient handling of the submission. Overall, it was a positive experience collaborating with your team.
Dear Mercy Grace, Editorial Coordinator of Obstetrics Gynecology and Reproductive Sciences, We would like to express our gratitude for your help at all stages of publishing and editing the article. The editors of the magazine answer all the necessary questions and help at every stage. We will definitely continue to cooperate and publish other works in the Obstetrics Gynecology and Reproductive Sciences! Best wishes from, Alla Konstantinovna Politova,